HDAC Inhibitors-New Generation of Target Specific Treatment

E-ISSN： 1875-5607|10|13|1263-1276

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.10, Iss.13, 2010-11, pp. : 1263-1276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie Altman Jessica K Platanias Leonidas C

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

HDAC as a Therapeutic Target for Treatment of Endometrial Cancers

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1847-1856

Bentham Science Publishers

Access to resources Recommend Favorite

Teratogenic Activity of HDAC Inhibitors

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5438-5442

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis

By Contestabile Antonio Sintoni Silvia Monti Barbara

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite